M&A · Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Mimedx Group, Inc. to acquire Sanara MedTech Inc.
Announced Jul 29, 2026 · Pending Sep 4, 2026
Deal value$350MEV $350M
Premium35.0%To unaffected price
EV / Adj. EBITDA7.2x3.3x EV / Revenue
ConsiderationCash and stock$35.00 per share
Transaction
- Acquirer
- Mimedx Group, Inc. (MDXG)
- Target
- Sanara MedTech Inc. (SMTI)
- Buyer type
- Strategic
- Offer price per share
- $35.00
- Enterprise value
- $350M
- Status
- Pending Sep 4, 2026
Deal protections
- Break fee (target pays)
- $9.7M · 2.8%
- Reverse fee (buyer pays)
- $22.5M · 6.4%
- Go-shop
- No-shop
- Financing
- Committed · Truist Securities
Advisors
- To the acquirer
- Centerview
- To the target
- Truist Securities
- Truist Securities fee
- $6.1M
Sector context · Healthcare
- Comparable deals
- 105 in the prior 24 months
- Premium
- 35.0% vs. 46.0% sector median
- EV / Adj. EBITDA
- 7.2x vs. 10.9x sector median
- Break fee
- 2.8% vs. 3.5% sector median
Timeline
- AnnouncedJul 29, 2026
- Proxy filedSep 4, 2026
- Definitive proxySep 4, 2026
- Shareholder votePending
- ClosedPending
Valuation · fairness opinions
Trading comparables$23.90$29.15
Trading comparables$25.15$31.70
Trading comparables$21.95$28.95
Trading comparables$25.75$36.25
Trading comparables$26.30$32.45
Offer $35.00
Implied value per Sanara MedTech Inc. share by analysis, from Truist Securities.